Open AccessJournal Article
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
Shaul G. Massry,Jack W. Coburn,Glenn M. Chertow,Keith A. Hruska,Craig B. Langman,Hartmut H. Malluche,Kevin J. Martin,Linda McCann,James T. McCarthy,Sharon M. Moe,Isidro B. Salusky,Donald J. Sherrand,Miroslaw Smogorzewski,Kline Bolton,Charles Turkelson,Karyn A. Tappe,Stephen Tregear,James Reston,Wendy Bruening,Mark Monteforte,Janice Kaczmarek,Vivian Coates,George R. Bailie,Bryan N. Becker,Gavin J. Becker,Jerrilynn D. Burrowes,Fernando Carrera,David N. Churchill,Allan J. Collins,Peter W. Crooks,Dick DeZeeuw,Thomas A. Golper,Frank A. Gotch,Antonio M. Gotto,Roger Greenwood,Joel W. Greer,Richard H. Grimm,William E. Haley,Ronald J. Hogg,Alan R. Hull,Lawrence G. Hunsicker,Cynda Ann Johnson,Michael J. Klag,Saulo Klahr,Norbert Lameire,Francesco Locatelli,Sally McCulloch,Maureen Michael,Joseph V. Nally,John M. Newmann,Allen R. Nissenson,Keith C. Norris,Gregorio T. Obrador,William F. Owen,Thakor G. Patel,Glenda Payne,Claudio Ronco,Rosa A. Rivera-Mizzoni,Anton C. Schoolwerth,Robert A. Star,Michael W. Steffes,Theodore I. Steinman,John Pierre Wauters,Nanette K. Wenger,Josephine P. Briggs,Thomas H. Hostetter,Garabed Eknoyan,Aderra Levin,Nathan W. Levin,Sharon Andreoli,Sally Burrows-Hudson,Derrick Latos,Donna Mapes,Edith Oberley,Brian J.G. Pereira,Nadine Ferguson,Donna Fingerhut,Anthony Gucciardo,Margaret Klette,Doreen Mallard,Kerry Willis +80 more
Reads0
Chats0
About:
This article is published in American Journal of Kidney Diseases.The article was published on 2003-10-01 and is currently open access. It has received 2609 citations till now. The article focuses on the topics: Chronic kidney disease-mineral and bone disorder & Kidney disease.read more
Citations
More filters
Journal ArticleDOI
Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study
José Luis Fernández-Martín,Pablo Martínez-Camblor,María P. Dionisi,Jürgen Floege,Markus Ketteler,Gérard M. London,Francesco Locatelli,José Luis Górriz,Bolesław Rutkowski,Aníbal Ferreira,Willem Jan W. Bos,Adrian Covic,Minerva Rodríguez-García,José Emilio Sánchez,Diego Rodríguez-Puyol,Jorge B. Cannata-Andía +15 more
TL;DR: Evidence is provided of the association of serum phosphorus, calcium and PTH and mortality, and survival benefits of controlling chronic kidney disease-mineral and bone disorder biochemical parameters in CKD5D patients are suggested.
Journal ArticleDOI
Osteoporosis after Solid Organ Transplantation
Naim M. Maalouf,Elizabeth Shane +1 more
TL;DR: The epidemiology of transplantation-related osteoporosis, the factors contributing to the pathogenesis of this complication, and the evaluation, prevention, and treatment options available for kidney, liver, lung, and heart transplant recipients are reviewed.
Journal ArticleDOI
The prevalence of phosphorus-containing food additives in top-selling foods in grocery stores.
TL;DR: Phosphorus additives are common in best-selling processed groceries and contribute significantly to their phosphorus content, and phosphorus additive foods are less costly than phosphorus additive-free foods.
Journal ArticleDOI
Hip Fracture in Patients With Non‐Dialysis‐Requiring Chronic Kidney Disease
TL;DR: Non‐dialysis‐requiring CKD is associated with higher age‐standardized rates of hip fracture and post‐hip fracture mortality and higher resource utilization.
Journal ArticleDOI
Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability
Angel L.M. de Francisco,Michael Leidig,Adrian Covic,Markus Ketteler,Ewa Benedyk-Lorens,Gabriel Mircescu,Caecilia Scholz,Pedro Ponce,Jutta Passlick-Deetjen +8 more
TL;DR: CaMg was non-inferior to the comparator at controlling serum phosphorus levels at Week 25, and had a good tolerability profile and thus may represent an effective treatment of hyperphosphataemia.
References
More filters
Journal ArticleDOI
Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
Geoffrey A. Block,Kevin J. Martin,Angel L.M. de Francisco,Stewart A. Turner,Morrell M. Avram,Michael Suranyi,Gavril Hercz,John Cunningham,Ali K. Abu-Alfa,Piergiorgio Messa,Daniel W. Coyne,Francesco Locatelli,Raphael M. Cohen,Pieter Evenepoel,Sharon M. Moe,Albert Fournier,Johann Braun,Laura C. McCary,Valter J. Zani,Kurt Olson,Tilman B. Drüeke,William G. Goodman +21 more
TL;DR: Cinacalcet lowers parathyroid hormone levels and improves calcium-phosphorus homeostasis in patients receiving hemodialysis who have uncontrolled secondary hyperparathyroidism.